Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT04640493
Eligibility Criteria:
Inclusion Criteria:
* Consent-able adults
* Diagnosis of heart failure
* Diagnosis of SDB
* No contraindication for taking dapagliflozin
Exclusion Criteria:
* Patients without heart failure
* Patients without SDB
* Contraindication for taking dapagliflozin (severe renal impairment, hemodialysis, or history of severe hypoglycemic episodes)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04640493
Study Brief:
Protocol Section:
NCT04640493